Author

Mark A. Currier

Nationwide Children's HospitalORCID 0000-0002-0064-2025Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Amy C. GrossiD· 1 shared Andrea M. GlaspelliD· 1 shared Chun‐Yu CheniD· 1 shared Dean Anthony LeeiD· 1 shared Elaine R. MardisiD· 1 shared Emily J. SchwarziD· 1 shared Emily M. RingwaltiD· 1 shared Laura E. BiedermaniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amy C. GrossORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular Therapy OncologyPeer-reviewedSep 26, 2024

Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma

Emily M. Ringwalt, Mark A. Currier, Andrea M. Glaspell…·Timothy P. Cripe

This study shows trabectedin enhances oncolytic virotherapy by reducing anti-viral barriers and boosting immune-mediated tumor regression in preclinical models.

9 citations

humanmouse

𝕏 PostBluesky